Pancreatic Cancer Research

ResearcherVA Greater Los Angeles Healthcare SystemActive in the last 2 years

James S. Tomlinson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8299-8211; OpenAlex author ID A5103143066. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
31
Papers, trials and grants by year

2013: 1 paper · 2014: 2 papers · 2015: 2 papers · 2016: 3 papers · 2017: none · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 12

  1. Identification of Tumor-Specific Surface Proteins Enables Quantification of Extracellular Vesicle Subtypes for Early Detection of Pancreatic Ductal Adenocarcin… Co-author DOI 10.1002/advs.202414982↗
  2. Circulating Fatty Objects and Their Preferential Presence in Pancreatic Cancer Patient Blood Samples. Co-author DOI 10.3389/fphys.2022.827531↗
  3. Pancreatic cancer circulating tumor cells: applications for personalized oncology. Last author DOI 10.1080/14737159.2018.1511429↗
  4. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer. Last author DOI 10.1245/s10434-017-6290-8↗
  5. Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer. Last author DOI 10.1016/j.jmoldx.2016.03.006↗
  6. Long-term survival in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.surg.2015.12.024↗
  7. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer. Last author DOI 10.1038/bjc.2016.121↗
  8. Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease. Co-author DOI 10.1002/jso.24011↗
  9. Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis. Last author DOI 10.1586/14737159.2015.1091311↗
  10. Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival. Co-author DOI 10.1001/jamasurg.2013.2690↗
  11. Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer. Co-author DOI 10.1097/sla.0000000000000378↗
  12. Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system. Last author DOI 10.1245/s10434-013-3159-3↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Colin M. Court · 5 shared papers, 2015–2018 · strength 0.35
  2. Stephen Jacob Pandol · 2 shared papers, 2022–2025 · strength 0.33
  3. Matthew M. Rochefort · 6 shared papers, 2013–2016 · strength 0.28
  4. Jacob S. Ankeny · 5 shared papers, 2013–2018 · strength 0.27
  5. Zev A. Wainberg · 5 shared papers, 2013–2018 · strength 0.25
  6. Timothy R. Donahue · 5 shared papers, 2013–2016 · strength 0.22
  7. Howard A. Reber · 5 shared papers, 2013–2016 · strength 0.22
  8. Oscar Joe Hines · 5 shared papers, 2013–2016 · strength 0.22
  9. Dekang Gao · 1 shared paper, 2025 · strength 0.17
  10. Chen Zhao · 1 shared paper, 2025 · strength 0.17
  11. Yazhen Zhu · 1 shared paper, 2025 · strength 0.17
  12. Dejun Liu · 1 shared paper, 2025 · strength 0.17
  13. Ruoxiang Wang · 1 shared paper, 2022 · strength 0.15
  14. Nicholas N. Nissen · 1 shared paper, 2022 · strength 0.15
  15. David W. Dawson · 3 shared papers, 2014–2016 · strength 0.15
  16. Benjamin J. DiPardo · 1 shared paper, 2018 · strength 0.12
  17. Mark D. Girgis · 2 shared papers, 2016–2018 · strength 0.12
  18. V. Raman Muthusamy · 2 shared papers, 2015–2016 · strength 0.09
  19. William H. Isacoff · 2 shared papers, 2013–2014 · strength 0.07
  20. Graham W. Donald · 2 shared papers, 2013–2014 · strength 0.07
  21. Brian E. Kadera · 2 shared papers, 2013–2014 · strength 0.07
  22. Alexander P. Stark · 1 shared paper, 2016 · strength 0.06
  23. Guido Eibl · 1 shared paper, 2016 · strength 0.06
  24. Greg D. Sacks · 1 shared paper, 2016 · strength 0.06
  25. Andrew Hieu Nguyen · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.